New PET scan could outshine CT for kidney cancer staging

NCT ID NCT04987086

Recruiting now Diagnosis Sponsor: Xijing Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a special PET scan (68Ga-PSMA) with standard CT scans to see which better detects where kidney cancer has spread in 300 adults with advanced disease. Participants will receive both scans, and doctors will check if the PET scan changes treatment plans. The goal is to improve accuracy and help guide better care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

kidney cancer metastatic neoplasm Neoplasm Metastasis renal carcinoma renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTASES PSMA PET RENAL CANCER

Contacts and locations

Locations

Affiliated Hospital of Yan'an University
RECRUITING

Yan’an, Shaanxi, China
General Hospital of Ningxia Medical University
RECRUITING

Yinchuan, Ningxia, China
Qinghai University Affiliated Hospital
RECRUITING

Xining, Qinghai, China
Shaanxi Provincial People's Hospital
RECRUITING

Xi'an, Shaanxi, China
The First Hospital of Lanzhou University
RECRUITING

Lanzhou, Gansu, China
The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
RECRUITING

Xianyang, Shaanxi, China
Weinan Central Hospital
RECRUITING

Weinan, Shaanxi, China
Xijing 986 Hospital
RECRUITING

Xi'an, Shaanxi, China
Xijing Hospital
RECRUITING

Xi'an, Shaan'xi, 710032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.